Wanbury Limited

Web: wanbury.com NSE: WANBURY BSE: 524212 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

244 2(-1%)

Volume

6L as on 23, Jun

Open

High

Low

246

VWAP

284

52 Week High

359

52 Week Low

162

Viand Research Rating

Quality Score

37/100

Growth Score

63/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

853

No. of Shares

3.5

P/E

28.35

P/B

27.8

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

98.09

ROCE

Profit Growth

Listing Date

29-Jan-07

Promoter Holding

43.01%

FII Holding

0.89%

DII Holding

0.06%

Price Chart

Price Performance

1 Week5%

1 Month6%

3 Months6%

6 Months19%

1 Year22%

YTD23%

Moving Average

5 Day SMA270

10 Day SMA268

20 Day SMA264

30 Day SMA263

50 Day SMA243

61 Day SMA240

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	292	276	285	293
Resistance 2	285	275	280	286
Resistance 1	279	274	277	280
Pivot Point	272	273	272	273
Support 1	266	272	267	267
Support 2	259	271	264	260
Support 3	253	269	259	254

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,271	1895	5%	3%	5%	20%	37	57.7	0.07	11509
2	DIVISLAB	2,46,156	9272	2%	13%	47%	55%	69	57.7	0	2568
3	TORNTPHARM	1,86,509	4904	3%	0%	14%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,26,078	8760	2%	2%	13%	13%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,13,576	1139	0%	4%	27%	15%	20	57.7	0.31	3560
6	CIPLA	1,11,872	1395	1%	5%	6%	9%	22	57.7	0.02	3862
7	LAURUSLABS	1,00,336	1857	2%	2%	83%	110%	0	57.7	0.48	890
8	LUPIN	96,762	2116	4%	11%	10%	8%	23	57.7	0.29	5355
9	DRREDDY	96,545	1144	1%	2%	12%	9%	20	57.7	0.2	4158
10	MANKIND	95,885	2322	4%	6%	6%	10%	49	57.7	0.39	1938
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 43.01%	(-0.11) 43.01%	(0.01) 43.08%	(3.51) 43.09%	(-0.11) 39.63%	(0.01) 39.76%	(0.01) 39.76%	(0.01) 39.77%	(0.01) 39.79%	(0.01) 39.79%	(0.01) 39.79%	(0.01) 39.80%	(0.01) 39.84%	(0.01) 39.84%	(0.01) 39.84%	(0.01) 39.85%	(0.01) 39.85%	(0.01) 39.89%	(0.01) 39.89%	(0.01) 39.90%
FIIs	(0.31) 0.89%	(-0.11) 0.59%	(-0.11) 0.72%	(-0.81) 0.82%	(0.01) 1.59%	(0.71) 1.55%	(-0.21) 0.84%	(0.81) 1.02%	(0.01) 0.22%	(0.21) 0.18%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.11) 0.06%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.01%
Public	56.04%	56.39%	56.21%	56.08%	58.79%	58.68%	59.40%	59.21%	59.97%	60.02%	60.20%	60.19%	60.16%	60.16%	60.16%	60.16%	60.15%	60.11%	60.11%	60.09%
No. of Shareholders	17,174	16,732	17,261	17,717	17,894	17,889	17,999	17,199	14,400	13,087	11,616	11,634	11,741	11,911	11,888	11,555	11,398	11,289	11,619	11,581

Quarterly Results

	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	163	172	133	161	131	139	146	144	146	133	126	124	117	134	124.84	124.09	127.86
Sales Growth % (YoY)	24.5%	23.4%	-8.3%	11.6%	-10.4%	4.8%	15.7%	16.5%	25.1%	-1%	0.8%	-0.1%	-8.5%	11.6%	13.8%	30.3%	90.4%
Sales Growth % (QoQ)	-5.2%	29.3%	-17.4%	22.9%	-5.8%	-4.8%	1.4%	-1.4%	9.8%	5.6%	1.6%	6%	-12.7%	7.3%	0.6%	-2.9%	-
Expenses	139	142	120	141	120	121	124	127	133	119	119	118	120	122	115.99	116.99	121.32
Operating Profit	24	30	14	20	11	18	21	17	13	14	6	6	-3	13	8.85	7.1	6.54
OPM %	15	17	10	12	8	13	15	12	9	11	5	4.5	-2.6	10	7.09	5.72	5.11
Other Income	0	2	1	2	1	26	1	1	1	-3	0	1	2	77	0.25	0.31	0.31
Interest	8	9	10	10	8	7	8	8	6	8	7	4	3	5	5.64	5.16	5.02
Depreciation	4	3	3	3	3	3	3	3	3	3	3	3	3	3	3.03	2.78	2.64
Profit before tax	14	19	1	8	1	34	10	7	5	1	-3	-1	-7	82	0.43	-0.53	-0.81
Tax %	1	-6	5	2	0	1	0	-2	6	-11	8	25	-3	-1	13.95	11.32	7.41
Net Profit	13	20	1	8	1	34	10	7	5	1	-3	-1	-7	83	0.37	-0.58	-0.86
Net Profit Growth % (QoQ)	-35%	1900%	-87.5%	700%	-97.1%	240%	42.9%	40%	400%	133.3%	-200%	85.7%	-108.4%	22332.4%	163.8%	32.6%	-
Net Profit Growth % (YoY)	1200%	-41.2%	-90%	14.3%	-80%	3300%	433.3%	800%	171.4%	-98.8%	-910.8%	-72.4%	-714%	-	-	-	-
TTM Net Profit	42	30	44	53	52	56	23	10	2	-10	72	75.37	75.79	81.93	-1.07	-1.44	0
EPS in Rs	4.1	6.18	0.37	2.45	0.32	10.27	3.14	2.25	1.43	0.31	-1	-0.27	-2.21	25.27	0.11	-0.18	-0.26

Profit and Loss

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2014	Mar 2013	Jan 1900
Sales	600	557	485	511	392	367	391	370	432	420	250	661	459	250
Sales Growth %	7.6%	14.8%	-5%	30.3%	6.8%	-6%	5.7%	-14.4%	2.9%	68.3%	-	44%	18.9%	-
Expenses	520	484	459	475	374	344	375	438	414	387	228	637	491	228
Operating Profit	80	73	26	36	18	23	16	-68	19	33	21	25	-32	21
OPM %	13	13	5	7	4.7	6	4.1	-18	4.3	8	9	4	-7	9
Other Income	0	26	-3	77	2	84	9	76	90	0	6	-78	5	6
Interest	37	29	21	21	23	33	40	31	36	32	19	48	37	19
Depreciation	13	13	12	11	10	10	10	10	10	9	5	23	23	5
Profit before tax	30	56	-10	81	-12	65	-25	-32	62	-7	4	-125	-87	4
Tax %	-3	1	1	0	2	0	-1	-1	1	0	28	2	0	28
Net Profit	31	56	-10	81	-13	64	-25	-32	62	-7	3	-128	-87	3
Net Profit Growth %	-44.6%	660%	-112.3%	723.1%	-120.3%	356%	21.9%	-151.6%	985.7%	-333.3%	102.3%	-47.1%	-3000%	-
EPS in Rs	9.32	17.09	-3.18	24.94	-5.04	25.79	-10.48	-13.49	26.71	-3.58	1.6	-63.95	-50.19	1.6
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2014	Mar 2013
Cash from Operating Activity	26	4	20	41	17	44	30	32	43	43	40	68	87
Cash from Investing Activity	-51	-17	-9	1	8	64	-3	-1	-13	-20	-5	-6	-21
Cash from Financing Activity	26	15	-32	-29	-17	-108	-27	-33	-27	-28	-30	-71	-64
Net Cash Flow	1	2	-21	13	7	0	0	-2	3	-5	5	-9	3

Balance Sheet

	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2014	Mar 2013
Equity Capital	33	33	33	33	33	25	25	24	24	23	20	20	20	17
Reserves	26	6	-5	-66	-56	-181	-168	-233	-208	-176	-209	-214	-212	-65
Borrowings	179	181	116	95	100	192	190	260	250	300	362	381	389	415
Other Liabilities	176	177	199	241	276	253	232	236	207	265	215	209	209	406
Total Liabilities	414	397	343	304	353	289	279	286	273	412	388	396	406	773
Fixed Assets	201	165	167	167	167	167	164	172	178	186	180	164	174	423
CWIP	5	16	3	2	2	11	14	9	10	10	14	19	13	25
Investments	0	2	0	0	0	0	0	0	0	0	0	0	0	1
Other Assets	208	214	174	135	183	111	101	105	84	216	193	213	219	324
Total Assets	414	397	343	304	353	289	279	286	273	412	388	396	406	773

Delivery

Delivery Data: WANBURY

#	Date	230 56% 359	Value (Cr)	Q/T 46	Del 42	Del 21
1	7-Sep	251	3	34	45	2
2	4-Sep	246	1	34	50	1
3	3-Sep	243	2	46	47	1
4	2-Sep	245	3	45	57	2
5	1-Sep	254	3	46	48	1
6	31-Aug	254	2	36	48	1
7	28-Aug	258	2	42	46	1
8	27-Aug	255	5	43	46	2
9	26-Aug	261	2	39	59	1
10	25-Aug	264	3	37	40	1
11	24-Aug	267	4	42	49	2
12	21-Aug	265	3	44	49	1
13	20-Aug	268	7	50	42	3
14	19-Aug	270	11	47	46	5
15	18-Aug	254	5	40	39	2
16	17-Aug	251	6	41	48	3
17	14-Aug	261	9	54	40	4
18	13-Aug	251	13	45	32	4
19	12-Aug	263	65	62	36	23
20	11-Aug	254	34	51	31	10
21	10-Aug	246	14	55	56	8
22	7-Aug	255	15	62	68	10
23	6-Aug	274	13	44	50	7
24	5-Aug	279	13	40	51	7
25	4-Aug	279	9	44	60	6
26	3-Aug	286	7	35	51	3
27	31-Jul	294	4	41	56	2
28	30-Jul	298	11	36	41	4
29	29-Jul	306	11	38	55	6
30	28-Jul	312	9	46	60	5
31	27-Jul	329	6	31	45	3
32	24-Jul	332	6	35	47	3
33	23-Jul	329	4	30	40	2
34	22-Jul	331	19	49	48	9
35	21-Jul	338	27	44	28	7
36	20-Jul	340	15	45	50	8
37	17-Jul	332	16	44	49	8
38	16-Jul	343	32	48	30	10
39	15-Jul	345	77	53	26	20
40	14-Jul	336	258	54	16	42
41	13-Jul	300	15	34	52	8
42	10-Jul	298	8	36	56	4
43	9-Jul	284	5	34	34	2
44	8-Jul	271	3	33	32	1
45	7-Jul	279	2	43	54	1
46	6-Jul	284	2	40	53	1
47	3-Jul	286	4	40	37	2
48	2-Jul	287	4	45	47	2
49	1-Jul	288	11	56	52	5
50	30-Jun	281	6	54	57	4

Daily Market Cap

Date	Total Market Cap	Change	Chg %
07-Sep	853c	9c	1.03
04-Sep	862c	19c	2.16
01-Sep	881c	16c	1.81
31-Aug	897c	4c	0.41
27-Aug	893c	27c	2.90
26-Aug	920c	2c	0.19
25-Aug	922c	3c	0.32
24-Aug	919c	7c	0.77
21-Aug	926c	10c	1.10
19-Aug	936c	42c	4.69
18-Aug	894c	16c	1.83
17-Aug	878c	20c	2.18
14-Aug	898c	4c	0.46
13-Aug	902c	16c	1.71
12-Aug	918c	41c	4.66
10-Aug	877c	14c	1.57
07-Aug	891c	58c	6.06
06-Aug	948c	10c	1.02
05-Aug	958c	17c	1.70
04-Aug	975c	34c	3.36
03-Aug	1,009c	12c	1.13
31-Jul	1,020c	26c	2.44
30-Jul	1,046c	46c	4.21
29-Jul	1,092c	1c	0.11
28-Jul	1,093c	0	0

Stock Checklist

Price is above from 52 week high low average: 42%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	-0.01%	0

Wanbury Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements